A CU Medicine provider.

I treat cardiovascular and peripheral vascular diseases with a team approach. My goal is to inform a patient about the condition or question, then listen and understand an individual’s unique values so we can choose the best treatment path forward that aligns with their goals. This includes through lifestyle changes as well as medical or percutaneous intervention when they are needed.

My time away from the hospital is devoted to my wife, three kids, and our needy labrador. I love getting outside in the Colorado mountains to cycle, ski, and hike.

Locations

Monday: 8am - 5pm
Tuesday: 8am - 5pm
Wednesday: 8am - 5pm
Thursday: 8am - 5pm
Friday: 8am - 5pm
Saturday: Closed
Sunday: Closed

Qualifications and experience

Specialties
Interventional Cardiology, Internal Medicine, Heart and Circulation - Angina, Heart and Circulation, Heart and Circulation - Angioplasty, Heart and Circulation - Coronary Disease, Heart and Circulation - Heart Attack, Heart and Circulation - Heart Valve Diseases, Heart and Circulation - Interventional Cardiology, Heart and Circulation - Peripheral Artery Disease , Heart and Circulation - Structural Heart Disease, Heart and Circulation - Transcatheter Aortic Valve Replacement (TAVR), General Cardiology
Gender
Male
Education
Fellowship
University of Colorado (2019)

Fellowship
University of Colorado (2018)

Fellowship
University of Colorado (2020)

Medical School
Temple University School of Medicine (2011)

Residency
University of Maryland Program (2014)

Undergraduate
University of California–Berkeley (CA) (2006)

Clinical interest for patients

My clinical focuses include the diagnosis and management of stable coronary and peripheral artery disease as well as the acute management of heart attacks. In addition I have a strong focus on prevention to reduce the risk of having a heart attack using lifestyle changes and established medical therapies, as well as offering options for investigational prevention therapies when appropriate for the individual. I am a site investigator for the EVOLVE-MI trial for early initiation of PCSK9 inhibitor after heart attack as well as the SPYRAL AFFIRM trial for renal artery denervation to treat chronically elevated blood pressure that has been resistant to medical therapy.

Insurance
UCHealth strongly encourages you to consult with your health insurer to determine accurate information about your coverage and benefits for a particular health care service provided at a UCHealth facility. Read more here.